European Commission approves linvoseltamab for the treatment of relapsed and refractory myelomaAccess, MyelomaApril 29, 2025
EMA CHMP gives positive opinion on linvoseltamab for relapsed/refractory myeloma patientsAccess, Myeloma, NewsMarch 3, 2025
Watch the recording of the EHA 2023 highlights webinarAL amyloidosis, MPE, Myeloma, VideosJuly 10, 2023
Watch the webinar “Importance of good nutrition and healthy diet for young myeloma patients”Myeloma, VideosOctober 18, 2024
Register for MPE´s European Young Myeloma Patients Group webinar on myeloma and physical fitnessMPE, Myeloma, NewsFebruary 5, 2025
The European Commission approves isatuximab + VRd combination therapy for newly diagnosed, transplant ineligible myeloma patientsAccess, Myeloma, NewsJanuary 24, 2025
